The Cardiovascular Event Risk Associated with Tyrosine Kinase Inhibitors and the Lipid Profile in Patients with Chronic Myeloid Leukemia.
- DOI
- 10.3390/hematolrep16010015
- Published
- 2024 Mar 12
- Container
- Hematology reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/hematolrep16010015,
title = {The Cardiovascular Event Risk Associated with Tyrosine Kinase Inhibitors and the Lipid Profile in Patients with Chronic Myeloid Leukemia.},
author = {Saez Perdomo MN and Stuckey R and González-Pérez E and Sánchez-Sosa S and Estupiñan-Cabrera P and Lakhwani Lakhwani S and González San Miguel JD and Hernanz Soler N and Gordillo M and González Brito G and Tapia-Torres M and Ruano A and Segura-Díaz A and Luzardo H and Bilbao-Sieyro C and Gómez-Casares MT},
year = {2024},
journal = {Hematology reports},
doi = {10.3390/hematolrep16010015},
url = {https://doi.org/10.3390/hematolrep16010015}
}RIS
TY - JOUR TI - The Cardiovascular Event Risk Associated with Tyrosine Kinase Inhibitors and the Lipid Profile in Patients with Chronic Myeloid Leukemia. AU - Saez Perdomo MN AU - Stuckey R AU - González-Pérez E AU - Sánchez-Sosa S AU - Estupiñan-Cabrera P AU - Lakhwani Lakhwani S AU - González San Miguel JD AU - Hernanz Soler N AU - Gordillo M AU - González Brito G AU - Tapia-Torres M AU - Ruano A AU - Segura-Díaz A AU - Luzardo H AU - Bilbao-Sieyro C AU - Gómez-Casares MT PY - 2024 JO - Hematology reports DO - 10.3390/hematolrep16010015 UR - https://doi.org/10.3390/hematolrep16010015 ER -
APA
MN, S. P., R, S., E, G., S, S., P, E., S, L. L., JD, G. S. M., N, H. S., M, G., G, G. B., M, T., A, R., A, S., H, L., C, B., & MT, G. (2024). The Cardiovascular Event Risk Associated with Tyrosine Kinase Inhibitors and the Lipid Profile in Patients with Chronic Myeloid Leukemia.. Hematology reports. https://doi.org/10.3390/hematolrep16010015
Source records
- pubmed · retrieved 2026-09-26T02:38:16.314Z